Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Amnionless-mediated glycosylation is crucial for cell surface targeting of cubilin in renal and intestinal cells.
|
29402915 |
2018 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Structural assembly of the megadalton-sized receptor for intestinal vitamin B12 uptake and kidney protein reabsorption.
|
30523278 |
2018 |
Megaloblastic Anemia 1
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Novel compound heterozygous mutations in AMN cause Imerslund-Gräsbeck syndrome in two half-sisters: a case report.
|
26040326 |
2015 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Novel compound heterozygous mutations in AMN cause Imerslund-Gräsbeck syndrome in two half-sisters: a case report.
|
26040326 |
2015 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Imerslund-Gräsbeck syndrome in a 25-month-old Italian girl caused by a homozygous mutation in AMN.
|
24044590 |
2013 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns.
|
22929189 |
2012 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
CLINVAR |
Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns.
|
22929189 |
2012 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Recessive mutations in CUBN or AMN cause Imerslund-Gräsbeck Syndrome (IGS), while recessive mutations in GIF cause Intrinsic Factor Deficiency (IFD).
|
22929189 |
2012 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Imerslund-Gräsbeck syndrome: new mutation in amnionless.
|
22631584 |
2012 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
One particular mutation in AMN, c.208-2A>G, causing an out-of-frame loss of exon 4 in the mRNA, is responsible for some 15% of IGS cases globally.
|
22078000 |
2011 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Luminal expression of cubilin is impaired in Imerslund-Grasbeck syndrome with compound AMN mutations in intron 3 and exon 7.
|
21750092 |
2011 |
Megaloblastic Anemia 1
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic heterogeneity of megaloblastic anaemia type 1 in Tunisian patients.
|
17285242 |
2007 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Biallelic mutations either in the cubilin (CUBN) or amnionless (AMN) gene cause IGS.
|
15738392 |
2005 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Several syndromes present with megaloblastic anemia such as congenital megaloblastic anemia due to intrinsic factor defect and juvenile megaloblastic anemia with proteinuria due to defects in the cubilin or the amnionless protein.
|
16047053 |
2005 |
Megaloblastic Anemia 1
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetically heterogeneous selective intestinal malabsorption of vitamin B12: founder effects, consanguinity, and high clinical awareness explain aggregations in Scandinavia and the Middle East.
|
15024727 |
2004 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
CLINVAR |
We show that homozygous mutations affecting exons 1-4 of human AMN lead to selective malabsorption of vitamin B12 (a phenotype associated with megaloblastic anemia 1, MGA1; OMIM 261100; refs.
|
12590260 |
2003 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
We show that homozygous mutations affecting exons 1-4 of human AMN lead to selective malabsorption of vitamin B12 (a phenotype associated with megaloblastic anemia 1, MGA1; OMIM 261100; refs.
|
12590260 |
2003 |
Megaloblastic Anemia 1
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
We show that homozygous mutations affecting exons 1-4 of human AMN lead to selective malabsorption of vitamin B12 (a phenotype associated with megaloblastic anemia 1, MGA1; OMIM 261100; refs.
|
12590260 |
2003 |
Megaloblastic Anemia 1
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We show that homozygous mutations affecting exons 1-4 of human AMN lead to selective malabsorption of vitamin B12 (a phenotype associated with megaloblastic anemia 1, MGA1; OMIM 261100; refs.
|
12590260 |
2003 |
Megaloblastic Anemia 1
|
0.770 |
Biomarker
|
disease |
CTD_human |
|
|
|
Megaloblastic anemia due to inborn errors of metabolism
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Novel compound heterozygous mutations in AMN cause Imerslund-Gräsbeck syndrome in two half-sisters: a case report.
|
26040326 |
2015 |
Kidney Failure, Acute
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failure.
|
20514524 |
2011 |
Megaloblastic anemia due to inborn errors of metabolism
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Luminal expression of cubilin is impaired in Imerslund-Grasbeck syndrome with compound AMN mutations in intron 3 and exon 7.
|
21750092 |
2011 |
Acute Kidney Insufficiency
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failure.
|
20514524 |
2011 |
Acute kidney injury
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failure.
|
20514524 |
2011 |